Daily News Archive
Daily News Subscription
New Salix Rule Among US RMTC Recommendations
The US Racing Medication & Testing Consortium board of directors “heard important updates from the organisation’s race day medication, drug testing initiative & research committees during a meeting in Arizona” reported bloodhorse.com. Items presented for discussion included “penalty guidelines, race day medication administration, security & surveillance, drug administration studies & the research being conducted under the RMTC-funded post-doctoral program”. National Thoroughbred Racing Association president Alex Waldrop “presented a model rule to reflect the RMTC’s earlier recommendations that furosemide (Salix) only be administered on race day by regulatory veterinarians”. The RMTC board voted “to approve the model rule presentation to the Association Of Racing Commissioners International winter meeting in Arizona on December 8 & 9”. Under the proposed language of the model rule, regulators or their designees “will have responsibility for race day administration of furosemide. The various adjunct bleeder medications that have been used in some jurisdictions would no longer be authorised.” To read the full report, click on the link in The Great Debate panel on the right-hand-side of this page.